KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Retained Earnings (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Retained Earnings for 17 consecutive years, with $16.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings rose 1464.78% to $16.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $16.9 billion, a 1464.78% increase, with the full-year FY2025 number at $16.9 billion, up 1464.78% from a year prior.
  • Retained Earnings was $16.9 billion for Q4 2025 at Bristol Myers Squibb, up from -$1.5 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $27.4 billion in Q2 2023 to a low of -$1.6 billion in Q2 2025.
  • A 5-year average of $7.8 billion and a median of -$1.3 billion in 2021 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: skyrocketed 2867.04% in 2023, then plummeted 109.65% in 2025.
  • Bristol Myers Squibb's Retained Earnings stood at -$1.3 billion in 2021, then soared by 2111.28% to $25.5 billion in 2022, then plummeted by 106.06% to -$1.5 billion in 2023, then rose by 19.92% to -$1.2 billion in 2024, then soared by 1464.78% to $16.9 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Retained Earnings are $16.9 billion (Q4 2025), -$1.5 billion (Q3 2025), and -$1.6 billion (Q2 2025).